In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
These observations are procedural in nature and will be responded within the stipulated time
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Subscribe To Our Newsletter & Stay Updated
